ENT Surgical Devices and Equipment Global Market Report 2024

The ent surgical devices and equipment market size has grown strongly in recent years. It will grow from $6.78 billion in 2023 to $7.35 billion in 2024 at a compound annual growth rate (CAGR) of 8.4%. The growth observed in the historical period can be attributed to several factors, including the increasing incidence of ENT disorders, a growing aging population, the rise in minimally invasive procedures within the field, heightened awareness and education regarding ENT health, and the development of healthcare infrastructure.

The ent surgical devices and equipment market size is expected to see strong growth in the next few years. It will grow to $9.93 billion in 2028 at a compound annual growth rate (CAGR) of 7.8%. Forecasted growth is due to increased demand for outpatient procedures, chronic ENT conditions, global healthcare expansion, patient-centric care focus, and cost-effective solutions. Major trends include AI integration, technological advancements, rapid innovations, surgical technology advancements, and a preference for ambulatory surgical centers (ASCs).

The growth of the ENT surgical devices and equipment market is anticipated to be fueled by the increasing prevalence of otorhinolaryngological (ENT) disorders. These medical conditions, affecting the ear, nose, and throat, drive the demand for advanced ENT surgical devices and equipment. These tools empower ENT specialists, enabling precise diagnosis and effective treatment of a broad spectrum of disorders related to the ear, nose, and throat. As of February 2023, the World Health Organization reported that approximately 5% of the global population requires rehabilitation to address hearing loss, and by 2050, it is projected that over 700 million people, or 1 in 10 individuals, will grapple with debilitating hearing impairment. Hence, the surge in ENT disorders acts as a catalyst for the growth of the ENT surgical devices and equipment market.

The future trajectory of the ENT surgical devices and equipment market is expected to be significantly influenced by the rising demand for and adoption of minimally invasive ENT surgeries. These procedures offer patients numerous advantages, including smaller incisions, quicker recovery times, diminished pain, and reduced scarring. Furthermore, these minimally invasive surgeries often provide physicians with enhanced accuracy compared to traditional open surgeries. The substantial benefits associated with minimally invasive ENT surgeries are poised to be a key driver of market growth.

A notable hindrance to the growth of the ENT surgical devices and equipment market is the inadequacy of proper reimbursement policies for ENT surgical procedures. This challenge is particularly pronounced in both developing and developed countries. Given the complexity and often higher costs associated with ENT surgical procedures, the absence of well-defined reimbursement policies may impede the market's expansion.

Minimally invasive ENT procedures, facilitated by advanced tools, present a viable alternative to major surgeries, offering benefits such as reduced tissue damage, minimized scarring, and quicker recovery. This approach is gaining widespread acceptance, contributing to increased market potential. The advent of robot-assisted minimally invasive procedures has particularly revolutionized the treatment landscape for ear, nose, and throat cancers. Transoral Robotic Surgery (TORS) is a widely adopted technique for addressing both benign and malignant conditions in the oropharynx and larynx.

Leading companies in the ENT surgical devices and equipment market are actively engaged in the development of cutting-edge technologies, with a specific focus on artificial intelligence (AI)-powered ENT navigation. ENT navigation involves the utilization of navigation systems in surgeries related to the ear, nose, and throat (ENT). In a significant development, Acclarent, Inc., a US-based healthcare company, introduced the first AI-powered ENT navigation technology in September 2021. This innovative software leverages machine learning algorithms to provide precise image-guided preoperative planning and navigation for ENT procedures, including endoscopic sinus surgery. The package incorporates TruSeg and TruPath, designed for use with the TruDi Navigation System, offering real-time 3D guidance, anatomical mapping, and surgical insights to enhance the efficiency of ENT procedures.

In May 2022, Medtronic PLC, a medical device company based in Ireland, successfully acquired Intersect ENT for an undisclosed amount. This strategic move by Medtronic is designed to broaden its Ear, Nose, and Throat (ENT) product portfolio. The acquisition adds innovative sinus implants, PROPEL and SINUVA, to Medtronic's offerings. These implants are unique bioabsorbable, steroid-eluting devices tailored for patients with sinus conditions. Intersect ENT, the acquired company, is based in the United States and specializes in developing cutting-edge medicines for ENT surgeons to enhance the health outcomes of their patients.

Major companies operating in the ent surgical devices and equipment market report are Primrose School Franchising Company, KinderCare Learning Companies Inc., Learning Care Group Inc., La Petite Academy, G8 Education, Cadence Education Inc., Bright Horizons Family Solutions Inc., The Learning Experience Corp., Kiddie Academy, Nobel Learning Communities Inc., Corinthian Colleges Inc., Childtime Learning Centers, Western Governors University, The Sunshine House Early Learning Academy, Children of America Inc., Goodstart Early Learning Ltd., Merryhill School, Kids 'R' Kids International, The Children's Courtyard, Children's Courtyard, The Children's Workshop, Walden University, The Gardner School, The Malvern School, Rainbow Child Care Center, Brighten Education Inc., Montessori Academy Inc., Tutor Time Child Care/Learning Centers, Discovery Point Child Development Centers, Kids & Co. Asia-Pacific was the largest region in the global ENT surgical devices and equipment market in 2023. North America was the second-largest region in the ENT surgical devices and equipment market. The regions covered in the ent surgical devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Key products within this segment include hand instruments, ENT surgical lasers, powered surgical systems, radiofrequency electrosurgical devices, ENT surgery workstations, surgical navigation systems, visualization systems, and surgical microscopes. These devices come in handheld, portable, and fixed formats. They cater to end-users such as hospitals, ambulatory surgical centers, and ENT clinics.

The ENT surgical devices and equipment market research report is one of a series of new reports that provides ENT surgical devices and equipment market statistics, including ENT surgical devices and equipment industry global market size, regional shares, competitors with a ENT surgical devices and equipment market share, detailed ENT surgical devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the ENT surgical devices and equipment industry. This ENT surgical devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The countries covered in the ent surgical devices and equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The ENT surgical devices and equipment market consists of sales of balloon sinus dilation devices, powered surgical instruments, ENT supplies, radiofrequency devices, ear tubes, and handheld instruments including the otology instrument, rhinology instrument, head and neck surgical instrument, laryngeal instrument, and other handheld instruments that are used for ENT surgeries. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.